277 related articles for article (PubMed ID: 31267214)
1. Interobserver agreement of whole-body magnetic resonance imaging is superior to whole-body computed tomography for assessing disease burden in patients with multiple myeloma.
Lai AYT; Riddell A; Barwick T; Boyd K; Rockall A; Kaiser M; Koh DM; Saffar H; Yusuf S; Messiou C
Eur Radiol; 2020 Jan; 30(1):320-327. PubMed ID: 31267214
[TBL] [Abstract][Full Text] [Related]
2. Assessing myeloma bone disease with whole-body diffusion-weighted imaging: comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease burden.
Giles SL; deSouza NM; Collins DJ; Morgan VA; West S; Davies FE; Morgan GJ; Messiou C
Clin Radiol; 2015 Jun; 70(6):614-21. PubMed ID: 25799364
[TBL] [Abstract][Full Text] [Related]
3. Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma.
Mesguich C; Hulin C; Latrabe V; Lascaux A; Bordenave L; Hindié E; Marit G
Ann Hematol; 2020 Dec; 99(12):2869-2880. PubMed ID: 32951093
[TBL] [Abstract][Full Text] [Related]
4. Repeatability and test-retest reproducibility of mean apparent diffusion coefficient measurements of focal and diffuse disease in relapsed multiple myeloma at 3T whole body diffusion-weighted MRI (WB-DW-MRI).
ElGendy K; Barwick TD; Auner HW; Chaidos A; Wallitt K; Sergot A; Rockall A
Br J Radiol; 2022 Sep; 95(1138):20220418. PubMed ID: 35867890
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer.
Michielsen K; Dresen R; Vanslembrouck R; De Keyzer F; Amant F; Mussen E; Leunen K; Berteloot P; Moerman P; Vergote I; Vandecaveye V
Eur J Cancer; 2017 Sep; 83():88-98. PubMed ID: 28734146
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Whole-Body DWI and
Chen J; Li C; Tian Y; Xiao Q; Deng M; Hu H; Wen B; He Y
AJR Am J Roentgenol; 2019 Sep; 213(3):514-523. PubMed ID: 31166755
[No Abstract] [Full Text] [Related]
7. Prediction of Early Treatment Response in Multiple Myeloma Using MY-RADS Total Burden Score, ADC, and Fat Fraction From Whole-Body MRI: Impact of Anemia on Predictive Performance.
Dong H; Huang W; Ji X; Huang L; Zou D; Hao M; Deng S; Shen Z; Lu X; Wang J; Song Z; Zhang X; Xue H; Xia S
AJR Am J Roentgenol; 2022 Feb; 218(2):310-319. PubMed ID: 34523949
[No Abstract] [Full Text] [Related]
8. Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: diagnostic accuracy and interobserver agreement for nodal and metastatic staging.
Johnston EW; Latifoltojar A; Sidhu HS; Ramachandran N; Sokolska M; Bainbridge A; Moore C; Ahmed HU; Punwani S
Eur Radiol; 2019 Jun; 29(6):3159-3169. PubMed ID: 30519933
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of whole-body CT and MRI versus projection radiography in the detection of osteolyses in patients with monoclonal plasma cell disease.
Wolf MB; Murray F; Kilk K; Hillengass J; Delorme S; Heiss C; Neben K; Goldschmidt H; Kauczor HU; Weber MA
Eur J Radiol; 2014 Jul; 83(7):1222-1230. PubMed ID: 24793843
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of computed tomography and diffusion-weighted imaging as first-line imaging modality according to the International Myeloma Working Group (IMWG) imaging algorithm for monoclonal plasma cell disorders.
Yoon MA; Chee CG; Chung HW; Lee DH; Kim KW
Acta Radiol; 2022 May; 63(5):672-683. PubMed ID: 33853375
[TBL] [Abstract][Full Text] [Related]
11. Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response.
Park HY; Kim KW; Yoon MA; Lee MH; Chae EJ; Lee JH; Chung HW; Yoon DH
Cancer Imaging; 2020 Jan; 20(1):14. PubMed ID: 32000858
[TBL] [Abstract][Full Text] [Related]
12. Whole-body MRI versus an FDG-PET/CT-based reference standard for staging of paediatric Hodgkin lymphoma: a prospective multicentre study.
Spijkers S; Littooij AS; Kwee TC; Tolboom N; Beishuizen A; Bruin MCA; Elias SG; van de Brug T; Enríquez G; Sábado C; Miller E; Granata C; de Lange C; Verzegnassi F; Greer MC; de Keizer B; Nievelstein RAJ
Eur Radiol; 2021 Mar; 31(3):1494-1504. PubMed ID: 32880696
[TBL] [Abstract][Full Text] [Related]
13. Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.
Noij DP; Boerhout EJ; Pieters-van den Bos IC; Comans EF; Oprea-Lager D; Reinhard R; Hoekstra OS; de Bree R; de Graaf P; Castelijns JA
Eur J Radiol; 2014 Jul; 83(7):1144-1151. PubMed ID: 24768188
[TBL] [Abstract][Full Text] [Related]
14. Quantification of tumor burden in multiple myeloma by atlas-based semi-automatic segmentation of WB-DWI.
Almeida SD; Santinha J; Oliveira FPM; Ip J; Lisitskaya M; Lourenço J; Uysal A; Matos C; João C; Papanikolaou N
Cancer Imaging; 2020 Jan; 20(1):6. PubMed ID: 31931880
[TBL] [Abstract][Full Text] [Related]
15. Inter-observer agreement of baseline whole body MRI in multiple myeloma.
Croft J; Riddell A; Koh DM; Downey K; Blackledge M; Usher M; Boyd K; Kaiser M; Messiou C
Cancer Imaging; 2020 Jul; 20(1):48. PubMed ID: 32665028
[TBL] [Abstract][Full Text] [Related]
16. Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT.
van Ufford HM; Kwee TC; Beek FJ; van Leeuwen MS; Takahara T; Fijnheer R; Nievelstein RA; de Klerk JM
AJR Am J Roentgenol; 2011 Mar; 196(3):662-9. PubMed ID: 21343511
[TBL] [Abstract][Full Text] [Related]
17. Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRI.
Zambello R; Crimì F; Lico A; Barilà G; Branca A; Guolo A; Varin C; Vezzaro R; Checuz L; Scapin V; Berno T; Pizzi M; Ponzoni A; De Biasi E; Vio S; Semenzato G; Zucchetta P; Lacognata C
Ann Hematol; 2019 Mar; 98(3):679-689. PubMed ID: 30539276
[TBL] [Abstract][Full Text] [Related]
18. Current concepts in tumor imaging with whole-body MRI with diffusion imaging (WB-MRI-DWI) in multiple myeloma and lymphoma.
Stecco A; Buemi F; Iannessi A; Carriero A; Gallamini A
Leuk Lymphoma; 2018 Nov; 59(11):2546-2556. PubMed ID: 29431555
[TBL] [Abstract][Full Text] [Related]
19. A survey study investigating perceptions and acceptance of the whole-body imaging techniques used for the diagnosis of myeloma.
Ryder A; Parsons C; Hutchinson CE; Greaney B; Thake CD
Radiography (Lond); 2021 Nov; 27(4):1149-1157. PubMed ID: 34257014
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B
Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
